Maynard Um
-
-
-
-
-
-
-
ProQR (PRQR) Announces CTA Submission for Phase 1 Study of AX-0810 Targeting NTCP
-
-
-
-
-
-
-
Citi Upgrades ProQR Therapeutics N.V. (PRQR) to Buy
-
-
-
-
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

